Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)

    NEXT STORY
    Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update
    PREV STORY
    ALBERTA BOEHRINGER INGELHEIM COLLABORATION FUND ANNOUNCES NEW RESEARCH FOR PATIENTS LIVING WITH RESPIRATORY DISEASE
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Epidemiologic Study Findings Show 27 Percent Increase in Emergency Department Visits for Gout in the United States Over the Past Decade

    -- Results reflect the undermanaged burden of uncontrolled gout --AMSTERDAM, The Netherlands, June 14, ...

    author_avatar
    NASDAQ Market News

    Merus to Present at the Jefferies 2018 London Healthcare Conference

    UTRECHT, The Netherlands, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Sunesis Pharmaceuticals Announces Promotion of Deborah A. Thomas, Ph.D., to Senior Vice President, Regulatory Affairs, Quality Assurance, and Non-Clinical Development

    SOUTH SAN FRANCISCO, Calif., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

    author_avatar
    NASDAQ Market News